The Claim

In patients with Hashimoto thyroiditis, FOXP3+ regulatory T cells exhibit CD25 expression levels that are not elevated relative to baseline, indicating the presence of a chronically activated regulatory T cell population that represents a late-stage phenotype distinct from classical CD25highFOXP3+ regulatory T cells.

Source: Interplay between expression of PD-L1 on thyrocytes and intrathyroidal lymphocytes and FOXP3 as a marker of regulatory T lymphocytes in Hashimoto thyroiditis.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
42score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Description
1 study reviewed
In plain English

In Hashimoto thyroiditis, a subset of regulatory T cells expresses FOXP3 but not elevated CD25, identifying a distinct cell population with a chronic activation profile different from the classical CD25highFOXP3+ regulatory T cells.

See the scientific wording

In Hashimoto thyroiditis, FOXP3+ regulatory T cells are present without a corresponding increase in CD25+ expression, suggesting a population of chronically activated regulatory T cells that may represent a late-stage phenotype distinct from classical CD25highFOXP3+ Tregs.

Why this might work

In the inflamed thyroid, persistent exposure to thyroid proteins keeps immune cells constantly active. Over time, the regulatory T cells that try to calm the attack lose their CD25 marker but keep producing FOXP3, becoming a stable, long-term suppressor type. These cells also express high levels of PD-1, which helps them interact with other cells to dampen the immune response without fully stopping it.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: Interplay between expression of PD-L1 on thyrocytes and intrathyroidal lymphocytes and FOXP3 as a marker of regulatory T lymphocytes in Hashimoto thyroiditis.

    In people with Hashimoto’s, the body’s immune system attacks the thyroid, and this study found special 'peacekeeper' immune cells (FOXP3+) are everywhere in the thyroid—but they’re missing a marker (CD25) that other peacekeepers usually have. This suggests they’re a different, long-term type of peacekeeper that’s been active for a while.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.